Literature DB >> 9135614

Eye drops and lethargy.

M D Vahidassr1, C J Foy, T O'Malley, A P Passmore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9135614      PMCID： PMC1296181          DOI： 10.1177/014107689709000310

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  6 in total

Review 1.  Potential side effects of timolol therapy in the treatment of glaucoma.

Authors:  T J Zimmerman; B J Leader; D S Golob
Journal:  Ann Ophthalmol       Date:  1981-06

2.  Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma.

Authors:  T J Zimmerman; H E Kaufman
Journal:  Arch Ophthalmol       Date:  1977-04

3.  Avoiding unsuspected respiratory side-effects of topical timolol with cardioselective or sympathomimetic agents.

Authors:  P Diggory; A Cassels-Brown; A Vail; L M Abbey; J S Hillman
Journal:  Lancet       Date:  1995-06-24       Impact factor: 79.321

4.  Timolol eyedrop-induced severe bronchospasm.

Authors:  S Ostergaard Laursen; P Bjerrum
Journal:  Acta Med Scand       Date:  1982

5.  Changes in depressive status associated with topical beta-blockers.

Authors:  S Duch; C Duch; L Pastó; P Ferrer
Journal:  Int Ophthalmol       Date:  1992-09       Impact factor: 2.031

6.  Adverse respiratory and cardiovascular events attributed to timolol ophthalmic solution, 1978-1985.

Authors:  W L Nelson; F T Fraunfelder; J M Sills; J B Arrowsmith; J N Kuritsky
Journal:  Am J Ophthalmol       Date:  1986-11-15       Impact factor: 5.258
  6 in total
  2 in total

Review 1.  Neuropsychiatric Adverse Events from Topical Ophthalmic Timolol.

Authors:  Nevio Cimolai
Journal:  Clin Med Res       Date:  2019-08-28

Review 2.  Systemic adverse effects of topical ophthalmic agents. Implications for older patients.

Authors:  J P Diamond
Journal:  Drugs Aging       Date:  1997-11       Impact factor: 3.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.